← back to search

Michael W. Kattan

Vanderbilt University Medical Center · US
Area of research
Pulmonary and Respiratory Medicine · Statistics and Probability
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Statistical Methods in Clinical Trials, and Health Systems, Economic Evaluations, Quality of Life.
h-index
146
citations
76,185
works
1,306
NIH funding
primary concept
email

Recent publications

A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection.
2026cited by 0position: contributordoi
Biological age model using explainable automated CT-based cardiometabolic biomarkers for phenotypic prediction of longevity
Nature Communications 2025cited by 21position: middledoi
Biological age model using explainable automated CT-based cardiometabolic biomarkers for phenotypic prediction of longevity.
2025cited by 9position: contributordoi
Are Statistical Tests Really Needed to Compare Training and Validation Sets for Prediction Model Development and Evaluation?
CHEST 2025cited by 0position: contributordoi
Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculator.
2024cited by 14position: contributordoi
Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection.
2024cited by 13position: contributordoi
Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
2024cited by 6position: contributordoi
Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.
2024cited by 5position: contributordoi
An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study.
2024cited by 3position: contributordoi
Pancreas Transplantation Outcome Predictions-PTOP: A Risk Prediction Tool for Pancreas and Pancreas-Kidney Transplants Based on a European Cohort.
2024cited by 2position: contributordoi
Proportion and predictors of FVC decline in patients with interstitial lung disease.
2024cited by 2position: contributordoi
Latent profiles of global electrical heterogeneity: the Hispanic Community Health Study/Study of Latinos.
2024cited by 2position: contributordoi
Image Guidance is Associated with Improved Freedom From Recurrence After Superficial Radiation Therapy for Nonmelanoma Skin Cancer
Advances in Radiation Oncology 2024cited by 2position: contributordoi
Surgeon Performance as a Predictor for Patient-Reported Outcomes After Arthroscopic Partial Meniscectomy.
2024cited by 0position: contributordoi
Development and validation of accelerated failure time model for cause-specific survival and prognostication of oral squamous cell carcinoma: SEER data analysis.
2024cited by 0position: contributordoi
Response.
2024cited by 0position: contributordoi
Factors Influencing Neuromuscular Blockade Reversal Choice in the United States Before and During the COVID-19 Pandemic: Retrospective Longitudinal Analysis.
2024cited by 0position: contributordoi
Predictors of Bone Loss in Anterior Glenohumeral Instability
The American Journal of Sports Medicine 2023cited by 19position: middledoi
Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection
American Journal of Transplantation 2023cited by 18position: middledoi
Methodologic Issues Specific to Prediction Model Development and Evaluation.
2023cited by 17position: contributordoi
Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis.
2023cited by 17position: contributordoi
Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality.
2023cited by 14position: contributordoi
Kidney Transplantation Outcome Predictions (KTOP): A Risk Prediction Tool for Kidney Transplants from Brain-dead Deceased Donors Based on a Large European Cohort.
2023cited by 13position: contributordoi
Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
2023cited by 11position: contributordoi
Consequences of preoperative cardiac stress testing-A cohort study.
2023cited by 10position: contributordoi
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease.
2023cited by 8position: contributordoi
Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery.
2023cited by 7position: contributordoi
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression.
2023cited by 6position: contributordoi
Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality
The Journal of Urology 2023cited by 5position: middledoi
Diagnostic and prognostic value of cardiac stress testing before major noncardiac surgery-A cohort study.
2023cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 36 papers (2019–2025)Dezheng Huo · Huanghuai University6 papers (2019–2020)Lara Jehi · Case Western Reserve University6 papers (2020–2021)Jacob Scott · University Hospitals Cleveland Medical Center6 papers (2020–2023)Philip R. Schauer · Providence College5 papers (2019–2021)Imad M. Najm · Cleveland Clinic4 papers (2019–2021)Yuxuan Jin · The Ohio State University Wexner Medical Center4 papers (2022–2025)Andrew J. Vickers · Nashville Oncology Associates4 papers (2012–2023)Bartolomé Burguera · Cleveland Clinic3 papers (2020–2020)Oğuz Akın · Manhattan Scientifics (United States)3 papers (2020–2021)Steven A. Eschrich · Moffitt Cancer Center3 papers (2020–2023)A. Ari Hakimi · Manhattan Scientifics (United States)3 papers (2014–2021) · 3 papers (2020–2020)Kevin M. Pantalone · University of Maryland Medical Center3 papers (2020–2021)Daniel M. Rotroff · Cleveland State University3 papers (2021–2023)Andrew J. Vickers · Nashville Oncology Associates3 papers (2020–2023) · 3 papers (2021–2022) · 3 papers (2021–2022)Hedvig Hricak · Medical University of Vienna3 papers (2021–2022)Kyle A. Blum · NewYork–Presbyterian Hospital2 papers (2020–2021)